Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
Julie Spellman Candy, Chair and CEO of Accenture plc (NYSE:ACN), a $220 billion market cap IT providers big with a “GOOD” InvestingPro Monetary Well being rating, executed a collection of inventory gross sales on January 17, in line with a…
Michael Heltzen, the Chief Government Officer of Invizyne Applied sciences Inc. (NASDAQ:IZTC), a $100 million market cap firm, not too long ago acquired further shares of the corporate, in line with a submitting with the Securities and Change Fee. In…
Yaacov Nagar, a major shareholder of 374Water Inc. (NASDAQ:SCWO), reported promoting a complete of 115,298 shares of the corporate’s widespread inventory over two days, in keeping with a latest SEC submitting. The transactions, executed on January 16 and 17, amounted…
Zachary Katz, Grindr Inc.’s (NYSE:GRND) Normal Counsel and Head of International Affairs, just lately offered a portion of his holdings within the firm. In response to a Kind 4 submitting with the Securities and Alternate Fee, Katz disposed of three,058…
RxSight, based mostly in Aliso Viejo, California, focuses on ophthalmic items and continues to be an lively participant within the medical expertise sector. The corporate maintains a strong stability sheet with more money than debt, positioning it effectively for future…
Bala Mohan, the Senior Vice President and Chief Growth Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago offered shares of the corporate as per a submitting with the Securities and Trade Fee. On January 16, Mohan offered 5,939…
Alejandra Carvajal, the Senior Vice President and Chief Authorized Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), lately offered shares of the corporate’s frequent inventory. The transaction, which passed off on January 16, concerned the sale of 5,096 shares at a weighted…
CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), a biotech firm with a market capitalization of $76.22 million, just lately disclosed a collection of transactions involving its Senior Vice President, Chief Working Officer, and Chief Monetary Officer, Brian DeSchuytner. The SEC submitting reveals…
CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), at the moment buying and selling close to its 52-week low of $0.56, lately disclosed that its President and CEO, Martin H. Huber Jr., executed a inventory sale valued at $2,618. The transaction concerned the…
In latest transactions disclosed by Mersana Therapeutics, Inc. (NASDAQ:MRSN), Timothy B. Lowinger, the corporate’s Senior Vice President and Chief Science & Know-how Officer, bought shares of widespread inventory valued at roughly $4,667. The inventory was bought on January 16 at…
